Liliane, Johannes, and Jose Sanchez-Mut show PM20D1-derived N-oleoyl-Leucine (OLE) improves AD pathologies in two animal models; first in vivo evidence for PM20D1-based therapy

Liliane, Johannes, and Jose Sanchez-Mut show PM20D1-derived N-oleoyl-Leucine (OLE) improves AD pathologies in two animal models; first in vivo evidence for PM20D1-based therapy Olé: Towards a PM20D1-based treatment of AD - EPFL Olé: Towards a PM20D1-based treatment of AD Import & publish the news Are you sure you want to import this news into ? This news will be sent to its subscribers. Together with former postdoc Jose Sanchez-Mut from the Alicante Neuroscience Institute, Liliane and Johannes showed how PM20D1-derived N-oleoyl-Leucine (OLE) improves AD pathologies in two animal models of Alzheimer’s disease. ...

May 5, 2026